Suchergebnisse - %22hydroxychloroquine%22

PubPharm (14)

1

MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition

enthalten in: The Journal of experimental medicine | 2023

von Silvis, M. | Silva, D. | Rohweder, R. | +7

2

Binding of hydroxychloroquine and chloroquine dimers to palmitoyl-protein thioesterase 1 (PPT1) and its glycosylated forms : a computational approach

enthalten in: Journal of biomolecular structure & dynamics | 2022

von Vergoten, G. | Bailly, C.

3

Computational study on the affinity of potential drugs to SARS-CoV-2 main protease

enthalten in: Journal of physics. Condensed matter : an Institute of Physics journal | 2022

von Martín, V. | Sanz-Novo, M. | León, I. | +3

4

Computational investigation of binding of chloroquinone and hydroxychloroquinone against PLPro of SARS-CoV-2

enthalten in: Journal of biomolecular structure & dynamics | 2022

von Patel, D. | Athar, M. | Jha, P.

5

Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking

enthalten in: Journal of nanoscience and nanotechnology | 2020

von Silva Arouche, T. | Reis, A. | Martins, A. | +3

6

Assessment of effective imidazole derivatives against SARS-CoV-2 main protease through computational approach

enthalten in: Life sciences | 2020

von Belhassan, A. | En-Nahli, F. | Zaki, H. | +2

7

Pharmacophore modelling of vanillin derivatives, favipiravir, chloroquine, hydroxychloroquine, monolaurin and tetrodotoxin as MPro inhibitors of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

enthalten in: BMC research notes | 2020

von Law, W. | Asaruddin, M. | Bhawani, S. | +1

8

Theoretical Insights into the Anti-SARS-CoV-2 Activity of Chloroquine and Its Analogs and In Silico Screening of Main Protease Inhibitors

enthalten in: Journal of proteome research | 2020

von Achutha, A. | Pushpa, V. | Suchitra, S.

9

Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2020

von Li, Z. | Li, X. | Huang, Y. | +14

CommentIn: Proc Natl Acad Sci U S A. 2021 Feb 23;118(8):. - PMID 33568498

10

In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection

enthalten in: International journal of antimicrobial agents | 2020

von Braz, H. | Silveira, J. | Marinho, A. | +4